13:50 ETREGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Bermanprnewswire·11 hours agoREGN+3.00%
Amgen says EU CHMP backs broader Repatha use to cut first heart attack, stroke riskPUBT·15 hours agoAMGN-1.39%
Amgen Inc Stock (AMGN) Moved Up by 4.02% on Jul 28: What Signal Does It Send?TradingKey·1 day ago, 01:18 PMAMGN-1.39%
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPR Newswire·1 day ago, 09:10 AMREGN+3.00%
AbCellera partners with Vertex to develop multispecific T-cell engagers for autoimmune diseases, other conditionsPUBT·17 hours agoVRTX-1.44%ABCL+1.89%
17:33 ETRegeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Lossesprnewswire·2 days ago, 04:34 PMREGN+3.00%
14:43 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Forte Biosciences, Inc. (NASDAQ: FBRX)prnewswire·2 days ago, 01:43 PMFBRX-0.16%ARGX+1.18%
FY2026 Earnings Forecast for argenex Issued By HC WainwrightMarket Beat·1 day ago, 05:12 AMARGX+1.18%
Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·8 hours agoVRTX-1.44%
Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsMarketWatch Automated·1 day ago, 03:38 PMVRTX-1.44%
Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·1 day ago, 03:36 PMGILD-1.18%
